Literature DB >> 9218999

Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization.

R A Altura1, J M Maris, H Li, J M Boyett, G M Brodeur, A T Look.   

Abstract

Childhood neuroblastoma, an embryonal neoplasm of sympathetic nervous system progenitors, occurs in a familial form with an autosomal dominant mode of inheritance. Genetic susceptibility to this disorder is thought to arise via a germline mutation affecting a tumor suppressor gene, in accord with the two-hit model established for familial and sporadic retinoblastoma. Surprisingly, the familial neuroblastoma predisposition locus does not map to chromosome band 1p36, a genomic region likely to contain one or more neuroblastoma suppressor genes. We reasoned that inherited point mutations affecting one allele would be unmasked in many cases by somatically acquired deletions of the second allele that included the target gene in the tumor cells from these patients. Thus, to identify chromosomal regions that might contain suppressor genes important in hereditary neuroblastoma, we analyzed six familial tumors by comparative genomic hybridization. Recurrent losses of genetic material were detected on chromosome arms 3p (consensus region, 3p24-pter), 10p (consensus, 10p12-p13), 10q (consensus, 10q25-qter), 16q (consensus, 16q12-q22), and 20q (consensus, 20q13.3-qter), in addition to the regions commonly deleted in sporadic neuroblastomas (1p36 and 11q). These chromosomal sites may harbor novel tumor suppressor genes that could aid in our understanding of the predisposition to and pathogenesis of familial neuroblastoma and potentially sporadic tumors as well.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218999     DOI: 10.1002/(sici)1098-2264(199707)19:3<176::aid-gcc7>3.0.co;2-v

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

1.  Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

Authors:  C Bai; B Connolly; M L Metzker; C A Hilliard; X Liu; V Sandig; A Soderman; S M Galloway; Q Liu; C P Austin; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.

Authors:  Hong-Wei Shen; Shun-Liang Gao; Yu-Lian Wu; Shu-You Peng
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 3.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.

Authors:  Paula Lázcoz; Jorge Muñoz; Manuel Nistal; Angel Pestaña; Ignacio Encío; Javier S Castresana
Journal:  BMC Cancer       Date:  2006-10-25       Impact factor: 4.430

Review 5.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma.

Authors:  Arko Sen; Yuchen Huo; Jennifer Elster; Peter E Zage; Graham McVicker
Journal:  Genome Biol       Date:  2022-03-04       Impact factor: 13.583

7.  FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.

Authors:  Kiyohiro Ando; Miki Ohira; Ichiro Takada; Verna Cázares-Ordoñez; Yusuke Suenaga; Hiroki Nagase; Shinichi Kobayashi; Tsugumichi Koshinaga; Takehiko Kamijo; Makoto Makishima; Satoshi Wada
Journal:  Cancer Sci       Date:  2021-11-30       Impact factor: 6.716

Review 8.  Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.

Authors:  Esteban Javier Rozen; Jason Matthew Shohet
Journal:  Cancer Metastasis Rev       Date:  2021-10-30       Impact factor: 9.264

9.  Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas.

Authors:  C Brinkschmidt; C Poremba; H Christiansen; R Simon; K L Schäfer; H J Terpe; F Lampert; W Boecker; B Dockhorn-Dworniczak
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  The Effect of X-Ray and Heavy Ions Radiations on Chemotherapy Refractory Tumor Cells.

Authors:  Zhan Yu; Carola Hartel; Diana Pignalosa; Wilma Kraft-Weyrather; Guo-Liang Jiang; David Diaz-Carballo; Marco Durante
Journal:  Front Oncol       Date:  2016-03-29       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.